Table 7.
Variable (N) | N (%) |
---|---|
Gender (174 patients) |
|
Male |
95 (54%) |
Female |
79 (45%) |
Median age (range), years |
69 (41 – 91) |
Median Karnofsky score (range) |
90 (50–100) |
Previous treatment |
|
Surgery |
22 (12%) |
External beam radiation |
7 (4.0%) |
Radiosurgery |
8 (4.6%) |
Chemo embolization |
1 (0.6%) |
Radiofrequency ablation |
5 (2.9%) |
Chemotherapy |
103 (59.2%) |
None |
54 (31.0%) |
Primary tumor site (204 lesions) |
|
Colorectal |
103 (50.5%) |
Lung |
22 (10.8%) |
Breast |
18 (8.8%) |
Pancreas |
9 (4.4%) |
Gynecological |
9 (4.4%) |
Gastric |
9 (4.4%) |
Head and neck |
7 (3.4%) |
Malignant melanoma |
4 (2.0%) |
Anal |
3 (1.5%) |
Kidney |
2 (1%) |
Intrahepatic bile duct |
2 (1%) |
Other |
14 (6.9%) |
Median lesion volume, cc |
27.3 (1–606) |
Median lesion size, cm |
2.7 (0.12 – 12.3) |
Median number of lesions (range) |
1(1–4) |
Median number of fractions |
3 (1–5) |
Median dose (range), Gy |
45 (10 – 61) |
Prescription dose range |
|
10 – 30 Gy |
35 (16.7%) |
33 – 39 Gy |
45 (21.6%) |
40 – 45 Gy |
42 (20.6%) |
46.5 – 48 Gy |
18 (8.8%) |
51 – 54 Gy |
38 (18.6%) |
57 – 60 Gy | 28 (13.7%) |